Xu Nuo

Mr. Xu Nuo


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2025 in Materials
Verified
Journal Article
Open access
PDF file
XHXulong Huang
Xulong Huang
WZWengang ZHao
Wengang ZHao
FKFarid Khalilov
Farid Khalilov
XNXu Nuo
Xu Nuo
Oxide (GO) has emerged as a highly versatile nanomaterial due to its exceptional physicochemical properties, including large surface area, and strong drug-loading capacity. These characteristics have enabled its broad application in fields such as wound healing, targeted drug delivery, and antimicrobial therapies. However, despite its promise, concerns surrounding GO’s cytotoxicity, biocompatibility, and potential pathological effects have limited its clinical translation. Addressing these limitations requires a deeper understanding of GO’s interactions with biological systems and the development of strategies to mitigate its adverse effects. Recent advances in surface functionalization, covalent crosslinking, and the incorporation of GO into biocompatible matrices have shown great potential in enhancing its performance while minimizing toxicity. This review provides a comprehensive overview of the antibacterial mechanisms of GO and highlights recent progress in chemical modification approaches that improve its efficacy in biomedical applications, particularly in wound healing and drug delivery. By critically examining both the advantages and limitations of GO, this work aims to inform future research directions and support the safe and effective integration of GO-based materials in advanced therapeutic systems.

31 March 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
SLShisheng Lin
Shisheng Lin
LTLu Tang
Lu Tang
XNXu Nuo
Xu Nuo
Fibroblast Growth Factor 21 (FGF21), a pivotal member of the fibroblast growth factor family, exhibits multifaceted biological functions, including the modulation of pro-inflammatory cytokines and metabolic regulation. Recent research has revealed that in impaired skin tissues, FGF21 and its receptors are upregulated and play a significant role in accelerating the wound healing process. However, the clinical application of FGF21 is severely limited by its short in vivo half-life: this factor is often degraded by enzymes before it can exert its therapeutic effects. To address this limitation, the transdermal drug delivery system (TDDS) has emerged as an innovative approach that enables sustained drug release, significantly prolonging the therapeutic duration. Leveraging genetic recombination technology, research teams have ingeniously fused FGF21 with cell-penetrating peptides (CPPs) to construct recombinant FGF21 complexes. These novel conjugates can efficiently penetrate the epidermal barrier and achieve sustained and stable pharmacological activity through TDDS. This review systematically analyzes the potential signaling pathways by which FGF21 accelerates skin wound repair, summarizes the latest advancements in TDDS technology, explores the therapeutic potential of FGF21, and evaluates the efficacy of CPP fusion tags. The manuscript not only proposes an innovative paradigm for the application of FGF21 in skin injury treatment but also provides new insights into its use in transdermal delivery, marking a significant step toward overcoming existing clinical therapeutic challenges. From a clinical medical perspective, this innovative delivery system holds promise for addressing the bioavailability issues of traditional FGF21 therapies, offering new strategies for the clinical treatment of metabolism-related diseases and wound healing. With further research, this technology holds vast potential for clinical applications in hard-to-heal wounds such as diabetic foot ulcers and burns.

2 April 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Open access
XXXiashun Xu
Xiashun Xu
XHXulong Huang
Xulong Huang
SLShisheng Lin
Shisheng Lin
GYGuangdong Yu
Guangdong Yu
JXJiali Xiao
Jiali Xiao
SGShuang Gao
Shuang Gao
Ultraviolet B (UVB) radiation exposure is a major contributor to skin photoaging, ultimately resulting in dryness. Conventional treatments for this condition frequently exhibit limited efficacy due to poor skin penetration and are associated with significant side effects. Saussurea involucrate polysaccharide (SIP) has been shown to alleviate photoaging-induced dry skin; however, its effectiveness is limited due to low drug utilization and the need for frequent dosing. In this study, we developed hyaluronic acid (HA) and ε-polylysine (ε-PLL) hydrogels designed to enhance skin hydration and enable sustained drug release. The optimal formulation, designated A5E3, contained 5 % HA plus 3 % ε-PLL. The sustained release of SIP from A5E3 demonstrated superior therapeutic effects in a mouse model of skin photoaging, including reduced inflammation and apoptosis, as well as enhanced keratinocyte differentiation and lipid production. The A5E3 hydrogel not only enhanced the drug utilization of SIP but also provided a sustained moisturizing environment, promoting faster skin repair. These findings support the development of skincare products with superior moisturizing and reparative properties, underscoring the potential of hydrogels as effective carriers for treating UVB-induced skin dryness and damage.

4 April 2025 in Frontiers in Plant Science
Verified
Journal Article
Open access
PDF file
GYGuangdong Yu
Guangdong Yu
SLShisheng Lin
Shisheng Lin
XHXulong Huang
Xulong Huang
SGShuang Gao
Shuang Gao
CSChengyang Song
Chengyang Song
XNXu Nuo
Xu Nuo
Epidermal growth factor (EGF) is recognized for its role in regulating keratinocyte proliferation and differentiation, thereby facilitating the restoration of impaired skin barriers. Nevertheless, challenges related to the penetration and safety of EGF remain to be resolved. In this study, we evaluated the efficacy of TDP1, a transdermal peptide, in enhancing the penetration of EGF through murine skin, utilizing EGF expressed in A. thaliana. The coding sequences of the TDP1 and EGF genes were cloned as a fusion construct into a plant expression vector. The resulting plasmid, pGM3301-TDP1-EGF, was introduced into A. thaliana via the floral dip method. Positive clones were identified using polymerase chain reaction (PCR). High-expression strains were selected through Western-blot analysis and enzyme-linked immunosorbent assay (ELISA). Homozygotes plants were obtained through self-pollination. The impact of the TDP1-EGF fusion protein on the restoration of a compromised epidermal barrier was assessed using dermatoscopy. Keratinocyte (KC) proliferation was examined via hematoxylin and eosin (H&E) staining, while KC differentiation, lipid synthesis, and inflammatory factors were analyzed using reverse transcription quantitative PCR (RT-qPCR) and immunohistochemistry. Compared to other expression systems, the A. thaliana system utilized for TDP1-EGF expression offers the advantages of being devoid of toxicity from endogenous plant substances, rendering it both safe and suitable for scalable production of the recombinant protein. The yield of the TDP1-EGF fusion protein expressed in A. thaliana accounted for 0.0166% of the total soluble protein. EGF conjugated with TDP1 displayed enhanced transdermal activity compared to unconjugated EGF, as evidenced by the Franz diffusion cell assay. Furthermore, the biological efficacy of the TDP1-EGF fusion protein surpassed that of EGF alone in ameliorating epidermal barrier damage in a murine skin injury model. This research has the potential to revolutionize the development and delivery of skincare products and establishes a foundation for the application of molecular farming in skin health.

13 July 2025 in Toxics
Verified
Journal Article
Open access
PDF file
JXJiali Xiao
Jiali Xiao
JWJunchao Wang
Junchao Wang
XNXu Nuo
Xu Nuo
XHXulong Huang
Xulong Huang
FKFarid Khalilov
Farid Khalilov
EKElchin Khalilov
Elchin Khalilov
Perfluorononanoic acid (PFNA) is a ubiquitous persistent environmental pollutant, and several studies have found significant links between atopic dermatitis (AD) and prenatal exposure to PFNA. However, the relationship between PFNA and AD remains unclear. In this study, 2,4-dinitrochlorobenzene (DNCB)-treated female BALB/c mice were used as AD models to investigate the effects of PFNA and its potential mechanisms. These mice were topically applied with 5 mg/kg PFNA per day for 15 days. The results demonstrated that PFNA significantly increased AD lesion severity and clinical symptoms, including dermatitis score, ear thickness, and epidermal thickness. In addition, PFNA also increased the serum IgE level, splenic atrophy, and upregulated the expression of TNF-α, IL-6, and IL-1β, genes that are associated with skin inflammatory factors. In addition, Western blot results showed that PFNA treatment upregulated the expression of p-JNK protein. Additionally, cellular experiments indicated that RAW264.7 macrophages and mouse brain microvascular endothelial (bEnd.3) cells treated with PFNA at concentrations of 0.01–100 μM for 72 h showed no changes in cell viability. However, 100 μM PFNA upregulated the mRNA expression levels of the pro-inflammatory cytokines IL-1β and IL-6, as well as the protein expression of p-JNK, in RAW264.7 cells induced with 1 mg/mL LPS for 2 h. Similarly, PFNA increased TNF-α and IL-6 mRNA expression and p-JNK protein expression in bEnd.3 cells stimulated with 20 ng/mL TNF-α for 0.5 h. Based on these findings, we can conclude that PFNA may aggravate atopic dermatitis by promoting inflammation.

27 May 2025 in PeerJ
Verified
Journal Article
Open access
PDF file
CSChengyang Song
Chengyang Song
GYGuangdong Yu
Guangdong Yu
SGShuang Gao
Shuang Gao
WZWengang Zhao
Wengang Zhao
YWYun-Peng Wang
Yun-Peng Wang
XNXu Nuo
Xu Nuo
This review examines the current research progress of molecular agriculture for cytokine expression, the research status of keratinocyte growth factor-2 (KGF-2) for skin care, hair growth, and the research status of plants for hair growth. KGF-2 application and use are inhibited by factors, such as the cost of production and efficacy due to low transdermal penetration potential. However, cell penetrating peptides (CPPs) are powerful transporter tools that assist the transmembrane delivery of attached biomacromolecules. Biomacromolecules such as KGF-2 have poor transdermal ability, which can be enhanced by combining with CPP such as TD1 to construct fusion proteins. Arabidopsis thaliana has many advantages, such as short growth cycle, high transformation efficiency, large biomass and hair growth promotion substances. Therefore, we also discuss the feasibility and expression strategies of using A. thaliana plant system to express fusion protein TDP1-KGF-2, which provides new idea for enhancing the transdermal ability of KGF-2 and providing new idea for plant system expression of fusion protein. This offers a promising new direction for the development of natural hair care and hair growth materials, as well as innovative possibilities for the application of molecular agriculture.